【正文】
sis. AIDS(London),2004,18:257264[6]Wiktor SZ,Sassan Morokro M,Grant AD,et of trimethoprimsulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV1infected patients with tuberculosis in Abidjan,Cote d’Ivoire:a randomized controlled trial[published erratum appears in Lancet 1999 Jun 12。353(9169):2078]. Lancet, 1999,353:14691475[7]JP Collet, P Shapiro, P Ernst, et al. Effects of an Immunostimulating Agent on Acute Exacerbations and Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease . The PARIIS Study Steering Committee and Research of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med, 1997,156: 17191724[8] 劉金來,錢孝賢. 病因?qū)W研究的循證醫(yī)學(xué)評(píng)價(jià). 循證醫(yī)學(xué),2002,2(4):230232[9]Atkins D, Best D, Briss PA, et al. Grading qual ity of evidence andstrength of remendations. BMJ, 2004, 328(7454): 14901494.[10]Laura Y. ParkWyllie, , et Gatifloxacin Therapy and Dysglycemia in Older Adults. The new england journal o f medicine, 2006, 354:135213615 /